دورية أكاديمية
Metal nanoparticles as a potential technique for the diagnosis and treatment of gastrointestinal cancer: a comprehensive review.
| العنوان: | Metal nanoparticles as a potential technique for the diagnosis and treatment of gastrointestinal cancer: a comprehensive review. |
|---|---|
| المؤلفون: | Roshani M; Internal Medicine and Gastroenterology, Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran., Rezaian-Isfahni A; Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran., Lotfalizadeh MH; North Khorasan University of Medical Sciences, Bojnurd, Iran., Khassafi N; Anatomical Sciences Research Center, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran., Abadi MHJN; Research Center for Health Technology Assessment and Medical Informatics, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. mohammadhassanj@gmail.com., Nejati M; Anatomical Sciences Research Center, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran. mnejatimt@gmail.com. |
| المصدر: | Cancer cell international [Cancer Cell Int] 2023 Nov 19; Vol. 23 (1), pp. 280. Date of Electronic Publication: 2023 Nov 19. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: BioMed Central Country of Publication: England NLM ID: 101139795 Publication Model: Electronic Cited Medium: Print ISSN: 1475-2867 (Print) Linking ISSN: 14752867 NLM ISO Abbreviation: Cancer Cell Int Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: London : BioMed Central, [2001- |
| مستخلص: | Gastrointestinal (GI) cancer is a major health problem worldwide, and current diagnostic and therapeutic approaches are often inadequate. Various metallic nanoparticles (MNPs) have been widely studied for several biomedical applications, including cancer. They may potentially overcome the challenges associated with conventional chemotherapy and significantly impact the overall survival of GI cancer patients. Functionalized MNPs with targeted ligands provide more efficient localization of tumor energy deposition, better solubility and stability, and specific targeting properties. In addition to enhanced therapeutic efficacy, MNPs are also a diagnostic tool for molecular imaging of malignant lesions, enabling non-invasive imaging or detection of tumor-specific or tumor-associated antigens. MNP-based therapeutic systems enable simultaneous stability and solubility of encapsulated drugs and regulate the delivery of therapeutic agents directly to tumor cells, which improves therapeutic efficacy and minimizes drug toxicity and leakage into normal cells. However, metal nanoparticles have been shown to have a cytotoxic effect on cells in vitro. This can be a concern when using metal nanoparticles for cancer treatment, as they may also kill healthy cells in addition to cancer cells. In this review, we provide an overview of the current state of the field, including preparation methods of MNPs, clinical applications, and advances in their use in targeted GI cancer therapy, as well as the advantages and limitations of using metal nanoparticles for the diagnosis and treatment of gastrointestinal cancer such as potential toxicity. We also discuss potential future directions and areas for further research, including the development of novel MNP-based approaches and the optimization of existing approaches. (© 2023. The Author(s).) |
| References: | Biomed Pharmacother. 2016 Dec;84:291-304. (PMID: 27665475) Mol Ther Nucleic Acids. 2021 Oct 08;26:892-926. (PMID: 34760336) Int J Mol Sci. 2018 Aug 02;19(8):. (PMID: 30072642) Methods Mol Biol. 2017;1530:319-336. (PMID: 28150211) Int J Nanomedicine. 2013;8:2153-61. (PMID: 23818775) Nat Nanotechnol. 2007 Dec;2(12):751-60. (PMID: 18654426) Beilstein J Nanotechnol. 2019 Jan 14;10:168-181. (PMID: 30746311) ACS Appl Mater Interfaces. 2023 Mar 8;15(9):11507-11519. (PMID: 36852669) Adv Drug Deliv Rev. 2010 Mar 8;62(3):346-61. (PMID: 19914317) Front Oncol. 2021 Apr 27;11:650256. (PMID: 33987085) Mater Sci Eng C Mater Biol Appl. 2020 Dec;117:111300. (PMID: 32919661) Oman Med J. 2018 Mar;33(2):111-117. (PMID: 29657679) Curr Drug Deliv. 2017;14(1):36-46. (PMID: 27538460) Nano Lett. 2015 Feb 11;15(2):842-8. (PMID: 25554860) J Gastroenterol. 2013 Jul;48(7):809-21. (PMID: 23179610) Iran J Pharm Res. 2020 Fall;19(4):306-320. (PMID: 33841544) Int J Nanomedicine. 2010 Aug 09;5:445-54. (PMID: 20957166) Cancer Lett. 2004 Jun 25;209(2):171-6. (PMID: 15159019) Life Sci. 2019 Oct 1;234:116758. (PMID: 31421083) Spectrochim Acta A Mol Biomol Spectrosc. 2015 Feb 5;136 Pt C:1249-54. (PMID: 25456666) Artif Cells Nanomed Biotechnol. 2018;46(sup1):499-510. (PMID: 29361855) Radiat Oncol. 2022 Mar 27;17(1):59. (PMID: 35346270) Chemphyschem. 2009 Jul 13;10(9-10):1461-5. (PMID: 19431161) Int J Nanomedicine. 2015 Apr 08;10:2823-46. (PMID: 25914533) Int J Mol Sci. 2023 Mar 02;24(5):. (PMID: 36902238) Nanotoxicology. 2013 Feb;7(1):21-9. (PMID: 22047053) Nanomedicine (Lond). 2007 Oct;2(5):681-93. (PMID: 17976030) Front Oncol. 2022 Dec 14;12:1014949. (PMID: 36591473) J Photochem Photobiol B. 2020 Jan;202:111698. (PMID: 31734436) Adv Drug Deliv Rev. 2017 Jan 15;109:84-101. (PMID: 26712711) Mater Sci Eng C Mater Biol Appl. 2018 Dec 1;93:465-471. (PMID: 30274079) Int J Mol Sci. 2022 Feb 01;23(3):. (PMID: 35163607) Mol Biol Rep. 2019 Oct;46(5):4725-4734. (PMID: 31222459) Pharmacol Res. 2020 Oct;160:105199. (PMID: 32942019) Sci Transl Med. 2013 Oct 30;5(209):209ra152. (PMID: 24174328) Int J Radiat Biol. 2017 Mar;93(3):315-323. (PMID: 27690719) Int J Nanomedicine. 2018 Oct 24;13:6809-6827. (PMID: 30425490) Nanomaterials (Basel). 2019 Dec 27;10(1):. (PMID: 31892149) Cell Death Dis. 2018 Feb 23;9(3):318. (PMID: 29476051) Int J Nanomedicine. 2016 Apr 29;11:1835-46. (PMID: 27199558) Int J Nanomedicine. 2020 Feb 13;15:991-1003. (PMID: 32103952) Adv Sci (Weinh). 2019 Jan 15;6(5):1801507. (PMID: 30886794) ACS Omega. 2018 Jan 31;3(1):1244-1262. (PMID: 30023799) Molecules. 2020 Jul 07;25(13):. (PMID: 32645899) Nanomaterials (Basel). 2019 Sep 18;9(9):. (PMID: 31540371) Biomaterials. 2010 Aug;31(23):5996-6003. (PMID: 20466420) Nanomedicine. 2018 Jan;14(1):1-12. (PMID: 28882675) 3 Biotech. 2021 Sep;11(9):401. (PMID: 34422541) Small. 2011 Nov 18;7(22):3158-62. (PMID: 21922667) Contrast Media Mol Imaging. 2014 Jan-Feb;9(1):53-61. (PMID: 24470294) Nat Rev Gastroenterol Hepatol. 2020 Apr;17(4):203-222. (PMID: 32099092) AAPS PharmSciTech. 2014 Dec;15(6):1527-34. (PMID: 25047256) Biomaterials. 2011 Dec;32(36):9796-809. (PMID: 21917309) J Biomed Nanotechnol. 2016 Jan;12(1):165-81. (PMID: 27301182) Nanomedicine (Lond). 2019 Jun;14(12):1565-1578. (PMID: 31215349) J Biomed Phys Eng. 2020 Apr 01;10(2):161-166. (PMID: 32337183) Int J Mol Sci. 2020 Nov 08;21(21):. (PMID: 33171604) Nat Prod Res. 2014;28(22):1964-9. (PMID: 24867679) Lab Chip. 2017 Jan 17;17(2):209-226. (PMID: 27991629) Adv Mater. 2010 Apr 22;22(16):1805-25. (PMID: 20512954) Lett Appl Microbiol. 2011 Jul;53(1):50-4. (PMID: 21535046) Carbohydr Polym. 2021 Apr 15;258:117719. (PMID: 33593581) Nat Rev Cancer. 2017 Jan;17(1):20-37. (PMID: 27834398) Naunyn Schmiedebergs Arch Pharmacol. 2021 Feb;394(2):279-289. (PMID: 32945892) Cell Stress. 2019 Jul 31;3(8):267-279. (PMID: 31440741) Lasers Surg Med. 2005 Aug;37(2):123-9. (PMID: 16047329) Oncotarget. 2017 Nov 20;9(4):4675-4697. (PMID: 29435134) Mol Ther Oncolytics. 2021 May 15;21:220-241. (PMID: 34095461) Invest New Drugs. 2018 Apr;36(2):332-339. (PMID: 28891038) Photodiagnosis Photodyn Ther. 2018 Sep;23:295-305. (PMID: 30048763) Int J Nanomedicine. 2020 Jul 27;15:5317-5331. (PMID: 32904434) Oncotarget. 2016 Dec 27;7(52):86675-86686. (PMID: 27880727) Int J Biol Macromol. 2021 Feb 28;171:198-207. (PMID: 33310102) FASEB J. 2017 Oct;31(10):4600-4611. (PMID: 28716969) Stem Cells Int. 2018 Feb 28;2018:5416923. (PMID: 29681949) Emergent Mater. 2022;5(6):1593-1615. (PMID: 35005431) Langmuir. 2006 Jan 3;22(1):2-5. (PMID: 16378388) ACS Omega. 2020 Nov 23;5(48):31227-31233. (PMID: 33324832) Anticancer Agents Med Chem. 2009 Feb;9(2):162-84. (PMID: 19199863) Int J Nanomedicine. 2020 May 21;15:3621-3637. (PMID: 32547018) Contemp Oncol (Pozn). 2021;25(1):45-52. (PMID: 33911981) Surgery. 2008 Aug;144(2):125-32. (PMID: 18656617) RSC Adv. 2019 Aug 8;9(42):24539-24559. (PMID: 35527869) Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3577-3584. (PMID: 31456423) World J Gastroenterol. 2016 Sep 14;22(34):7645-59. (PMID: 27678348) Int J Mol Sci. 2021 Feb 17;22(4):. (PMID: 33671292) Biomaterials. 2016 May;87:46-56. (PMID: 26897539) Talanta. 2011 Oct 30;86:157-63. (PMID: 22063525) Int J Nanomedicine. 2015 Jul 03;10:4321-40. (PMID: 26170667) Biomed Pharmacother. 2021 Oct;142:112024. (PMID: 34399200) Cancer Manag Res. 2018 Feb 07;10:239-248. (PMID: 29445300) Int J Nanomedicine. 2008;3(3):351-8. (PMID: 18990944) Nanoscale Res Lett. 2018 Sep 10;13(1):279. (PMID: 30203228) J Nanobiotechnology. 2019 Jul 5;17(1):80. (PMID: 31277667) Asian Pac J Cancer Prev. 2019 Nov 01;20(11):3369-3376. (PMID: 31759361) Biomed Pharmacother. 2022 Sep;153:113274. (PMID: 35724505) Proc Natl Acad Sci U S A. 2015 May 5;112(18):5573-8. (PMID: 25902507) Mol Biol Rep. 2022 Jan;49(1):705-715. (PMID: 34677714) Int J Mol Sci. 2015 Sep 16;16(9):22415-24. (PMID: 26389895) Oncol Rep. 2014 Sep;32(3):1200-10. (PMID: 24993451) Frontline Gastroenterol. 2013 Jan;4(1):57-68. (PMID: 28839701) Int J Nanomedicine. 2006;1(2):149-54. (PMID: 17722530) J Ultrasound Med. 2013 Mar;32(3):475-83. (PMID: 23443188) Arch Dermatol Res. 2000 Dec;292(12):583-9. (PMID: 11214818) Front Oncol. 2021 Oct 11;11:752784. (PMID: 34707995) Int J Nanomedicine. 2010 Oct 05;5:771-81. (PMID: 21042423) Nat Commun. 2017 Apr 25;8:15130. (PMID: 28440296) J Photochem Photobiol B. 2020 Jan;203:111749. (PMID: 31884347) Semin Cancer Biol. 2022 Nov;86(Pt 2):1056-1065. (PMID: 34843989) Drug Dev Ind Pharm. 2001 Nov;27(10):1063-72. (PMID: 11794809) ACS Nano. 2016 Dec 27;10(12):10636-10651. (PMID: 27758098) Bioimpacts. 2020;10(1):27-36. (PMID: 31988854) J Phys Chem B. 2006 Oct 5;110(39):19220-5. (PMID: 17004772) Expert Opin Pharmacother. 2017 Jan;18(1):35-44. (PMID: 27849399) Pharmacol Res. 2020 Nov;161:105133. (PMID: 32822869) Clin Cancer Res. 2020 Apr 15;26(8):1877-1885. (PMID: 31941831) J Pharm Pharm Sci. 2011;14(1):67-77. (PMID: 21501554) Mater Sci Eng C Mater Biol Appl. 2019 Apr;97:498-509. (PMID: 30678937) Chem Commun (Camb). 2009 Oct 21;(39):5874-6. (PMID: 19787126) Semin Cancer Biol. 2020 Feb;60:334-343. (PMID: 31445220) Bioinorg Chem Appl. 2018 Jul 5;2018:1062562. (PMID: 30073019) Mikrochim Acta. 2019 Aug 23;186(9):641. (PMID: 31444649) Nanotechnology. 2022 Jan 07;33(13):. (PMID: 34937004) Theranostics. 2018 Apr 3;8(10):2621-2633. (PMID: 29774063) Acc Chem Res. 2008 Dec;41(12):1578-86. (PMID: 18447366) Ann N Y Acad Sci. 2009 Apr;1161:62-73. (PMID: 19426306) Int J Med Sci. 2020 Mar 12;17(6):824-833. (PMID: 32218704) Biotechnol Adv. 2009 Jan-Feb;27(1):76-83. (PMID: 18854209) J Photochem Photobiol B. 2016 Aug;161:375-82. (PMID: 27318296) Front Pharmacol. 2021 Dec 21;12:680400. (PMID: 34992527) Biomater Sci. 2016 Dec 20;5(1):77-88. (PMID: 27822577) Eur Arch Otorhinolaryngol. 2015 Oct;272(10):2629-42. (PMID: 25082176) J Control Release. 2012 Dec 10;164(2):115-24. (PMID: 22484196) J Am Chem Soc. 2012 Jan 25;134(3):1376-91. (PMID: 22229439) J Am Chem Soc. 2019 Dec 4;141(48):19032-19037. (PMID: 31729871) J Cancer Res Clin Oncol. 2018 Aug;144(8):1463-1473. (PMID: 29858680) Biomed Pharmacother. 2017 May;89:1067-1077. (PMID: 28292015) J Phys Chem Lett. 2014 Aug 7;5(15):2594-600. (PMID: 26277949) Gastroenterology. 2020 Jul;159(1):335-349.e15. (PMID: 32247694) An Acad Bras Cienc. 2020 Nov 16;92(4):e20200574. (PMID: 33206791) Adv Biomed Res. 2015 Mar 25;4:69. (PMID: 25878994) Cancer Gene Ther. 2021 Dec;28(12):1229-1255. (PMID: 33432087) Int J Med Sci. 2019 Oct 21;16(12):1541-1548. (PMID: 31839741) Sensors (Basel). 2019 May 09;19(9):. (PMID: 31075985) J Mater Chem B. 2018 Aug 14;6(30):4852-4871. (PMID: 32255062) J Nanobiotechnology. 2022 Oct 8;20(1):441. (PMID: 36209164) J Biomed Res. 2015 Aug 5;29:. (PMID: 26423611) Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):30-44. (PMID: 30663395) World J Gastroenterol. 2014 Oct 14;20(38):13804-19. (PMID: 25320518) Artif Cells Nanomed Biotechnol. 2020 Dec;48(1):1206-1213. (PMID: 33016139) J Pharm Pharmacol. 2008 Aug;60(8):977-85. (PMID: 18644191) Biochem Biophys Res Commun. 2017 Jun 03;487(3):709-715. (PMID: 28442344) Nanomaterials (Basel). 2020 Feb 23;10(2):. (PMID: 32102185) Colloids Surf B Biointerfaces. 2010 Aug 1;79(1):5-18. (PMID: 20417070) Nanoscale Adv. 2021 Mar 8;3(9):2516-2528. (PMID: 36134160) J Cell Physiol. 2019 Sep;234(9):15527-15536. (PMID: 30697733) Anal Bioanal Chem. 2008 Jun;391(3):943-50. (PMID: 18157524) Nano Lett. 2007 Jul;7(7):1929-34. (PMID: 17550297) J Nanosci Nanotechnol. 2019 Nov 1;19(11):6942-6948. (PMID: 31039845) Nanotechnology. 2020 Mar 27;31(13):135102. (PMID: 31783387) Front Pharmacol. 2021 Aug 11;12:668567. (PMID: 34456716) Adv Colloid Interface Sci. 2009 Jan 30;145(1-2):83-96. (PMID: 18945421) Int J Biol Macromol. 2017 Dec;105(Pt 1):608-619. (PMID: 28716752) Bioconjug Chem. 2017 Jan 18;28(1):222-229. (PMID: 27771945) Adv Drug Deliv Rev. 1998 Oct 5;34(1):109-119. (PMID: 10837673) Oncol Rep. 2016 Mar;35(3):1457-62. (PMID: 26648165) J Adv Res. 2016 Jan;7(1):17-28. (PMID: 26843966) Nanomedicine. 2018 Aug;14(6):1919-1929. (PMID: 29885899) Toxicol Lett. 2017 Jul 5;276:11-20. (PMID: 28483428) Nanomedicine. 2019 Oct;21:102070. (PMID: 31351238) ACS Infect Dis. 2018 Aug 10;4(8):1162-1178. (PMID: 29860830) Nanomaterials (Basel). 2021 May 11;11(5):. (PMID: 34064899) Mater Sci Eng C Mater Biol Appl. 2020 May;110:110684. (PMID: 32204112) Toxicol Appl Pharmacol. 2010 Aug 1;246(3):116-27. (PMID: 20434478) Mol Cancer Ther. 2014 Jul;13(7):1740-9. (PMID: 24825856) Small. 2011 Jan 3;7(1):126-36. (PMID: 21104804) Part Fibre Toxicol. 2011 May 14;8:16. (PMID: 21569586) ChemistryOpen. 2023 Jun;12(6):e202200250. (PMID: 37260410) Chem Soc Rev. 2008 Sep;37(9):1896-908. (PMID: 18762838) Drug Deliv. 2022 Dec;29(1):664-678. (PMID: 35209786) Pharmaceutics. 2021 Oct 18;13(10):. (PMID: 34684019) Int J Toxicol. 2014 Mar-Apr;33(2):86-97. (PMID: 24510415) J Genet Eng Biotechnol. 2021 Jan 14;19(1):9. (PMID: 33443619) |
| فهرسة مساهمة: | Keywords: Gastrointestinal cancers; Metal nanoparticles; Therapy |
| تواريخ الأحداث: | Date Created: 20231120 Latest Revision: 20231122 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC10657605 |
| DOI: | 10.1186/s12935-023-03115-1 |
| PMID: | 37981671 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder كن أول من يترك تعليقا!